Daniel Walls

Daniel Walls

Auto-generated profile, based on publicly available information

Daniel Walls

Department of Otolaryngology, Head and Neck Surgery, University of Iowa, Iowa, IA, United States

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Cell Reports
Verified
Journal Article
Open access
PRPaul T. Ranum
Paul T. Ranum
AGAlexander T. Goodwin
Alexander T. Goodwin
HYHidekane Yoshimura
Hidekane Yoshimura
DKDiana L. Kolbe
Diana L. Kolbe
WWWilliam D. Walls
William D. Walls
RSRichard J. H. Smith
Richard J. H. Smith
Single-cell RNA sequencing is a powerful tool by which to characterize the transcriptional profile of low-abundance cell types, but its application to the inner ear has been hampered by the bony labyrinth, tissue sparsity, and difficulty dissociating the ultra-rare cells of the membranous cochlea. Herein, we present a method to isolate individual inner hair cells (IHCs), outer hair cells (OHCs), and Deiters' cells (DCs) from the murine cochlea at any post-natal time point. We harvested more than 200 murine IHCs, OHCs, and DCs from post-natal days 15 (p15) to 228 (p228) and leveraged both short- and long-read single-cell RNA sequencing to profile transcript abundance and structure. Our results provide insights into the expression profiles of these cells and document an unappreciated complexity in isoform variety in deafness-associated genes. This refined view of transcription in the organ of Corti improves our understanding of the biology of hearing and deafness.

7 May 2020 in Human Genetics
Verified
Journal Article
Closed access
PDF file
WWW. Daniel Walls
W. Daniel Walls
HMHideaki Moteki
Hideaki Moteki
TTTaylor R. Thomas
Taylor R. Thomas
Shinya NishioShinya Nishio
Shinya Nishio
HYHidekane Yoshimura
Hidekane Yoshimura
TCThomas L. Casavant
Thomas L. Casavant

3 October 2025 in JMIR Preprints
Verified
Preprint
Open access
BDBenjamin DeSollar
Benjamin DeSollar
NSNathan Schaefer
Nathan Schaefer
DWDaniel Walls
Daniel Walls
AOAmanda M. Odell
Amanda M. Odell
KBKevin TA Booth
Kevin TA Booth
ACAnd Thomas Casavant
And Thomas Casavant
BACKGROUND Autosomal dominant non-syndromic hearing loss (ADNSHL) is highly heterogeneous, with more than 64 genes implicated in its etiology. This complexity limits the diagnostic power of clinical examinations and audiometry alone, while existing computational approaches have achieved only moderate accuracy and often lack interpretability. As precision medicine increasingly emphasizes genotype-phenotype correlations, there is a pressing need for diagnostic tools that provide clinicians with transparent, interpretable outputs. OBJECTIVE This study aimed to develop and evaluate the AudioGene Translational Dashboard (AGTD), an interpretable clinical informatics tool that integrates machine learning models and interactive visualizations to enhance genotype–phenotype correlation and support diagnostic decision-making in autosomal dominant non-syndromic hearing loss (ADNSHL). METHODS We developed the AGTD, integrating two sophisticated machine learning models (AG4 and AG9.1) with six interactive visualization tools. AG4 utilizes a multi-instance support vector machine classifier for patients with multiple audiograms, while AG9.1 combines adaptive boosting, k-nearest neighbors, random forest models, and logistic regression for patients with a single audiogram. Visualizations include audiometric profile plots, Audioprofile surfaces, clustering analyses, and data distribution charts designed to facilitate clinical interpretation. RESULTS AGTD introduced the ‘70/30’ rule, indicating a 74% likelihood that the causative gene is among the top three predicted genes, thereby providing clinicians a clear confidence indicator ('green flag') or caution alert ('red flag') during diagnosis. Visualization tools significantly enhanced clinicians' ability to interpret and correlate phenotypic data with predicted genetic outcomes, improving diagnostic confidence and interpretability. CONCLUSIONS The AGTD significantly advances clinical informatics in genetic diagnostics of ADNSHL by integrating explainable AI and interactive visualizations, enhancing clinical interpretability and diagnostic accuracy. This approach facilitates informed clinical decision-making, highlights the translational potential of genotype-phenotype computational models, and supports precision medicine in hearing loss diagnostics. Future enhancements will target improving class balance and incorporating additional user-customizable features to further optimize clinical applicability.

29 September 2025 in Human Genetics
Verified
Journal Article
Open access
JCJoseph J. Chin
Joseph J. Chin
WWW. Daniel Walls
W. Daniel Walls
KWKai Wang
Kai Wang
AOAmanda M. Odell
Amanda M. Odell
DKDiana L. Kolbe
Diana L. Kolbe
RSRichard J. H. Smith
Richard J. H. Smith
Despite advances in the genetic diagnosis of hearing loss, there remains room for improvement. One way to improve the genetic diagnostic rate is the proper assessment of synonymous variants that are often bioinformatically filtered out. We used GSDME as a model to demonstrate the importance of assessing synonymous variants. Variants in the gene GSDME (also known as DFNA5 ) are associated with autosomal dominant nonsyndromic hearing loss. The hearing loss is typically progressive and downsloping. All reported causative variants of GSDME -related hearing loss involve the skipping of exon 8, which results in the expression of a constitutively active, but truncated protein that induces apoptosis of cochlear hair cells. A retrospective search of previously tested patients identified 3 novel pathogenic synonymous GSDME variants. The functional impact of these variants was confirmed in vitro via a minigene splicing assay. We also observed variant-dependent differences in the levels of aberrant splicing, leading us to hypothesize that partial loss of splicing will result in a less severe hearing loss phenotype as compared to complete loss of splicing. Audiometric analysis found an association between complete loss of splicing and greater initial and/or more quickly progressing hearing loss as compared to partial loss of splicing. Over the course of the study, we also found limited correlation between in silico prediction and in vitro observed effects of a variant on splicing, indicating the need to cautiously apply in silico prediction tools in the context of genetic diagnosis.

14 April 2026 in JMIR Bioinformatics and Biotechnology
Verified
Journal Article
Open access
BDBenjamin DeSollar
Benjamin DeSollar
NSNathan Schaefer
Nathan Schaefer
DWDaniel Walls
Daniel Walls
AOAmanda M Odell
Amanda M Odell
KBKevin TA Booth
Kevin TA Booth
ACAnd Thomas Casavant
And Thomas Casavant
Background: Autosomal dominant nonsyndromic hearing loss (ADNSHL) is highly heterogeneous, with more than 64 genes implicated in its etiology. This complexity limits the diagnostic power of clinical examinations and audiometry alone, while existing computational approaches have achieved only moderate accuracy and often lack interpretability. As precision medicine increasingly emphasizes genotype-phenotype correlations, there is a recognized need for diagnostic tools that provide clinicians with transparent, interpretable outputs. Objective: This study aimed to develop and evaluate the AudioGene Translational Dashboard, an interpretable clinical informatics tool that integrates machine learning models and interactive visualizations to enhance genotype-phenotype correlations and support diagnostic decision-making in ADNSHL. Methods: We developed the AudioGene Translational Dashboard, integrating 2 machine learning models (AudioGene version 4 and AudioGene version 9.1) with 6 interactive visualization tools. AudioGene version 4 uses a multi-instance support vector machine classifier for patients with multiple audiograms, while AudioGene version 9.1 combines adaptive boosting, k-nearest neighbors, random forest models, and logistic regression for patients with a single audiogram. Visualizations include audiometric profile plots, audioprofile surfaces, clustering analyses, and data distribution charts designed to facilitate clinical interpretation. Results: The AudioGene Translational Dashboard was developed to address the “70/30” phenomenon, indicating a 74% likelihood that the causative gene is among the top 3 predicted genes, thereby providing clinicians with a clear confidence indicator (“green flag”) or a caution alert (“red flag”) during diagnosis. While this level of performance is well suited for hypothesis generation, the remaining uncertainty underscores the need for interpretive context in clinical decision-making. Visualization tools enhanced clinicians’ ability to interpret and correlate phenotypic data with predicted genetic outcomes, improving diagnostic confidence and interpretability. Conclusions: The AudioGene Translational Dashboard advances clinical informatics in genetic diagnosis of ADNSHL by integrating explainable artificial intelligence with interactive visualizations, enhancing clinical interpretability and diagnostic accuracy. This approach facilitates informed clinical decision-making, highlights the translational potential of genotype-phenotype computational models, and supports precision medicine in hearing loss diagnostics. Future enhancements will target improving class balance and incorporating additional user-customizable features to further optimize clinical applicability.